Please provide your email address to receive an email when new articles are posted on . Among 336 patients with asthma, 46 also had major depressive disorder. There were longitudinal associations ...
Austin psychiatrist Dr. Donald J. Garcia is enrolling patients in a study on a new kind of medication for major depressive disorder. While drug companies have created many medications that help ...
A team of leading clinical research scientists from the Departments of Psychiatry and Dermatology at the Icahn School of Medicine at Mount Sinai has found that the serum of patients with major ...
Psychiatric disorders like schizophrenia, bipolar disorder, and depression have a strong genetic signature. Through advanced transcriptome-wide association studies (TWAS), researchers can identify ...
Findings provide rationale for targeted strategy in psychiatry that may lead to new personalized treatments for major depressive disorder and other conditions ...
Breakthrough study finds single dose of psychedelics significantly reduced depression symptoms in clinical trial, with ...
Myriad Genetics, Inc. announced that a study published in the Journal of Clinical Psychopharmacology found that the GeneSight® Psychotropic Test significantly reduced psychiatric hospitalizations in ...
Major depressive disorder is a debilitating condition that impacts around 5% of adults worldwide. While doctors commonly prescribe antidepressants to patients, it has several side effects and might ...
NEW HAVEN, Conn., Dec. 24, 2025 /PRNewswire/ -- Biohaven Ltd. (BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of ...
This trip might just be worth taking. New research suggests that microdosing a popular psychedelic may provide relief for people struggling with major depressive disorder. That’s noteworthy, since ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results